Research graph
References from Combined hepatocellular cholangiocarcinoma: A rare hepatic malignancy exhibiting concurrent imaging features of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2019 · External reference
An updated review of combined hepatocellular cholangiocarcinoma: a rare and poorly understood neoplasm
10.3390/diagnostics16020314 · 2026 · External reference
Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management
10.1159/000530700 · 2023 · External reference
The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value
10.1007/s11547-023-01682-x · 2023 · External reference
MRI features of combined hepatocellular-cholangiocarcinoma
10.1007/s00261-024-04476-5 · 2025 · External reference
Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma
10.1007/s00330-022-09065-y · 2022 · External reference
Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients
10.1148/radiol.2018181494 · 2018 · External reference
Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction
10.1007/s00330-022-09131-5 · 2023 · External reference
Pathology of cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
10.1002/cld.1047 · 2021 · External reference
Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection
2020 · External reference
Pathology of cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
10.1002/cld.1047 · ExternalCitation · doi-reference
MRI features of combined hepatocellular-cholangiocarcinoma
10.1007/s00261-024-04476-5 · ExternalCitation · doi-reference
Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma
10.1007/s00330-022-09065-y · ExternalCitation · doi-reference
Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction
10.1007/s00330-022-09131-5 · ExternalCitation · doi-reference
The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value
10.1007/s11547-023-01682-x · ExternalCitation · doi-reference
Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients
10.1148/radiol.2018181494 · ExternalCitation · doi-reference
Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management
10.1159/000530700 · ExternalCitation · doi-reference
An updated review of combined hepatocellular cholangiocarcinoma: a rare and poorly understood neoplasm
10.3390/diagnostics16020314 · ExternalCitation · doi-reference